Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Evaluating the User Experience and Usability of the MINI Robot for Elderly Adults with Mild Dementia and Mild Cognitive Impairment: Insights and Recommendations

  • Mahmoudi Asl, Aysan
  • Toribio Guzmán, José Miguel
  • Castro González, Álvaro
  • Malfaz Vázquez, María Ángeles
  • Salichs Sánchez-Caballero, Miguel
  • Franco Martín, Manuel
Introduction: In recent years, the integration of robotic systems into various aspects of daily life has become increasingly common. As these technologies continue to advance, ensuring user-friendly interfaces and seamless interactions becomes more essential. For social robots to genuinely provide lasting value to humans, a favourable user experience (UX) emerges as an essential prerequisite. This article aimed to evaluate the usability of the MINI robot, highlighting its strengths and areas for improvement based on user feedback and performance. Materials and Methods: In a controlled lab setting, a mixed-method qualitative study was conducted with ten individuals aged 65 and above diagnosed with mild dementia (MD) and mild cognitive impairment (MCI). Participants engaged in individual MINI robot interaction sessions, completing cognitive tasks as per written instructions. Video and audio recordings documented interactions, while post-session System Usability Scale (SUS) questionnaires quantified usability perception. Ethical guidelines were followed, ensuring informed consent, and the data underwent qualitative and quantitative analyses, contributing insights into the MINI robot’s usability for this demographic. Results: The study addresses the ongoing challenges that tasks present, especially for MD individuals, emphasizing the importance of user support. Most tasks require both verbal and physical interactions, indicating that MD individuals face challenges when switching response methods within subtasks. These complexities originate from the selection and use of response methods, including difficulties with voice recognition, tablet touch, and tactile sensors. These challenges persist across tasks, with individuals with MD struggling to comprehend task instructions and provide correct answers and individuals with MCI struggling to use response devices, often due to the limitations of the robot’s speech recognition. Technical shortcomings have been identified. The results of the SUS indicate positive perceptions, although there are lower ratings for instructor assistance and pre-use learning. The average SUS score of 68.3 places device usability in the “good” category. Conclusions: Our study examines the usability of the MINI robot, revealing strengths in quick learning, simple system and operation, and integration of features, while also highlighting areas for improvement. Careful design and modifications are essential for meaningful engagement with people with dementia. The robot could better benefit people with MD and MCI if clear, detailed instructions and instructor assistance were available., This research was carried out as part of theMarie Curie Innovative Training Network (ITN) action, H2020-MSCA-ITN-2018, under grant agreement number 813196. Also, The research leading to development and study on the Mini robot has received funding from the following projects: Robots Sociales para Estimulación Física, Cognitiva y Afectiva de Mayores (ROSES), RTI2018-096338-B-I00, funded by theMinisterio de Ciencia, Innovación y Universidades, Spanish government, Robots sociales para mitigar la soledad y el aislamiento en mayores (SOROLI), PID2021-123941OA-I00, funded by Agencia Estatal de Investigación (AEI),Ministerio de Ciencia e Innovación, Spanish government.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Predicting emotional states using behavioral markers derived from passively sensed data: Data-driven machine learning approach

  • Sükei, Emese
  • Norbury, Agnes
  • Perez-Rodriguez, M. Mercedes
  • Martínez Olmos, Pablo
  • Artés Rodríguez, Antonio
Background: Mental health disorders affect multiple aspects of patients’ lives, including mood, cognition, and behavior. eHealth and mobile health (mHealth) technologies enable rich sets of information to be collected noninvasively, representing a promising opportunity to construct behavioral markers of mental health. Combining such data with self-reported information about psychological symptoms may provide a more comprehensive and contextualized view of a patient’s mental state than questionnaire data alone. However, mobile sensed data are usually noisy and incomplete, with significant amounts of missing observations. Therefore, recognizing the clinical potential of mHealth tools depends critically on developing methods to cope with such data issues. Objective: This study aims to present a machine learning–based approach for emotional state prediction that uses passively collected data from mobile phones and wearable devices and self-reported emotions. The proposed methods must cope with high-dimensional and heterogeneous time-series data with a large percentage of missing observations. Methods: Passively sensed behavior and self-reported emotional state data from a cohort of 943 individuals (outpatients recruited from community clinics) were available for analysis. All patients had at least 30 days’ worth of naturally occurring behavior observations, including information about physical activity, geolocation, sleep, and smartphone app use. These regularly sampled but frequently missing and heterogeneous time series were analyzed with the following probabilistic latent variable models for data averaging and feature extraction: mixture model (MM) and hidden Markov model (HMM). The extracted features were then combined with a classifier to predict emotional state. A variety of classical machine learning methods and recurrent neural networks were compared. Finally, a personalized Bayesian model was proposed to improve performance by considering the individual differences in the data and applying a different classifier bias term for each patient. Results: Probabilistic generative models proved to be good preprocessing and feature extractor tools for data with large percentages of missing observations. Models that took into account the posterior probabilities of the MM and HMM latent states outperformed those that did not by more than 20%, suggesting that the underlying behavioral patterns identified were meaningful for individuals’ overall emotional state. The best performing generalized models achieved a 0.81 area under the curve of the receiver operating characteristic and 0.71 area under the precision-recall curve when predicting self-reported emotional valence from behavior in held-out test data. Moreover, the proposed personalized models demonstrated that accounting for individual differences through a simple hierarchical model can substantially improve emotional state prediction performance without relying on previous days’ data. Conclusions: These findings demonstrate the feasibility of designing machine learning models for predicting emotional states from mobile sensing data capable of dealing with heterogeneous data with large numbers of missing observations. Such models may represent valuable tools for clinicians to monitor patients’ mood states., This project has received funding from the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement number 813533. This work was partly supported by the Spanish government (Ministerio de Ciencia e Innovación) under grants TEC2017-92552-EXP and RTI2018-099655-B-100; the Comunidad de Madrid under grants IND2017/TIC-7618, IND2018/TIC-9649, IND2020/TIC-17372, and Y2018/TCS-4705; the BBVA Foundation under the Domain Alignment and Data Wrangling with Deep Generative Models (Deep-DARWiN) project; and the European Union (European Regional Development Fund and the European Research Council) through the European Union's Horizon 2020 Research and Innovation Program under grant 714161. The authors thank Enrique Baca-Garcia for providing demographic and clinical data and assisting in interpreting and summarizing the data.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Shift in social media app usage during covid-19 lockdown and clinical anxiety symptoms: Machine learning-based ecological momentary assessment study

  • Ryu, Jihan
  • Sükei, Emese
  • Norbury, Agnes
  • Liu, Shelley H
  • Campaña Montes, Juan José
  • Baca García, Enrique
  • Artés Rodríguez, Antonio
  • Perez-Rodriguez, M. Mercedes
Background: Anxiety symptoms during public health crises are associated with adverse psychiatric outcomes and impaired health decision-making. The interaction between real-time social media use patterns and clinical anxiety during infectious disease outbreaks is underexplored. Objective: We aimed to evaluate the usage pattern of 2 types of social media apps (communication and social networking) among patients in outpatient psychiatric treatment during the COVID-19 surge and lockdown in Madrid, Spain and their short-term anxiety symptoms (7-item General Anxiety Disorder scale) at clinical follow-up. Methods: The individual-level shifts in median social media usage behavior from February 1 through May 3, 2020 were summarized using repeated measures analysis of variance that accounted for the fixed effects of the lockdown (prelockdown versus postlockdown), group (clinical anxiety group versus nonclinical anxiety group), the interaction of lockdown and group, and random effects of users. A machine learning–based approach that combined a hidden Markov model and logistic regression was applied to predict clinical anxiety (n=44) and nonclinical anxiety (n=51), based on longitudinal time-series data that comprised communication and social networking app usage (in seconds) as well as anxiety-associated clinical survey variables, including the presence of an essential worker in the household, worries about life instability, changes in social interaction frequency during the lockdown, cohabitation status, and health status. Results: Individual-level analysis of daily social media usage showed that the increase in communication app usage from prelockdown to lockdown period was significantly smaller in the clinical anxiety group than that in the nonclinical anxiety group (F1,72=3.84, P=.05). The machine learning model achieved a mean accuracy of 62.30% (SD 16%) and area under the receiver operating curve 0.70 (SD 0.19) in 10-fold cross-validation in identifying the clinical anxiety group. Conclusions: Patients who reported severe anxiety symptoms were less active in communication apps after the mandated lockdown and more engaged in social networking apps in the overall period, which suggested that there was a different pattern of digital social behavior for adapting to the crisis. Predictive modeling using digital biomarkers—passive-sensing of shifts in category-based social media app usage during the lockdown—can identify individuals at risk for psychiatric sequelae., JR was supported by the American Psychiatric Association 2021 Junior Psychiatrist Research Colloquium (NIDA R-13 grant). ES received funding from the European Union Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant 813533). AA is supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (RTI2018-099655-B-I00), the Comunidad de Madrid (Y2018/TCS-4705 PRACTICO-CM), and the BBVA Foundation (Deep-DARWiN grant).
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Automatic patient functionality assessment from multimodal data using deep learning techniques - Development and feasibility evaluation

  • Sükei, Emese
  • León-Martínez, Santiago de
  • Martínez Olmos, Pablo
  • Artés Rodríguez, Antonio
Wearable devices and mobile sensors enable the real-time collection of an abundant source of physiological and behavioural data unobtrusively. Unlike traditional in-person evaluation or ecological momentary assessment (EMA) questionnaire-based approaches, these data sources open many possibilities in remote patient monitoring. However, defining robust models is challenging due to the data's noisy and frequently missing observations. This work proposes an attention-based Long Short-Term Memory (LSTM) neural network-based pipeline for predicting mobility impairment based on WHODAS 2.0 evaluation from such digital biomarkers. Furthermore, we addressed the missing observation problem by utilising hidden Markov models and the possibility of including information from unlabelled samples via transfer learning. We validated our approach using two wearable/mobile sensor data sets collected in the wild and socio-demographic information about the patients. Our results showed that in the WHODAS 2.0 mobility impairment prediction task, the proposed pipeline outperformed a prior baseline while additionally providing interpretability with attention heatmaps. Moreover, using a much smaller cohort via task transfer learning, the same model could learn to predict generalised anxiety severity accurately based on GAD-7 scores., ES received funding from the European Union Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant 813533) . AA and PO are supported by the Spanish government MCI under grants PID2021-123182OB-I00 and PID2021-125159NB-I00, by Comunidad de Madrid under grant IND2022/TIC-23550, by the European Research Council (ERC) through the European Union's Horizon 2020 research and innovation program under Grant 714161, and by Comunidad de Madrid and FEDER through IntCARE-CM.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

A historical perspective of biomedical explainable AI research

  • Malinverno, Luca
  • Barros, Vesna
  • Ghisoni, Francesco
  • Visonà, Giovanni
  • Kern, Roman
  • Nickel, Philip J.
  • Ventura, Barbara Elvira
  • Simic, Ilija
  • Stryeck, Sarah
  • Manni, Francesca
  • Jean-Quartier, Claire
  • Genga, Laura
  • Schweikert, Gabriele
  • Lovric, Mario
  • Ferri Ramírez, César|||0000-0002-8975-1120
[EN] The black-box nature of most artificial intelligence (AI) models encourages the development of explainability methods to engender trust into the AI decision-making process. Such methods can be broadly categorized into two main types: post hoc explanations and inherently interpretable algorithms. We aimed at analyzing the possible associations between COVID-19 and the push of explainable AI (XAI) to the forefront of biomed-ical research. We automatically extracted from the PubMed database biomedical XAI studies related to con-cepts of causality or explainability and manually labeled 1,603 papers with respect to XAI categories. To compare the trends pre-and post-COVID-19, we fit a change point detection model and evaluated significant changes in publication rates. We show that the advent of COVID-19 in the beginning of 2020 could be the driving factor behind an increased focus concerning XAI, playing a crucial role in accelerating an already evolving trend. Finally, we present a discussion with future societal use and impact of XAI technologies and potential future directions for those who pursue fostering clinical trust with interpretable machine learning models., We are extremely grateful for Prof. Chris Holmes for his critical reading and valuable comments. We acknowledge the funding received from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie Sk1odowska-Curie Grant agreement no. 813533-MSCA-ITN-2018. I.S. was funded by the "DDAI" COMET Module within the COMET - Competence Centers for Excellent Technologies Programme, funded by the Austrian Federal Ministry for Transport, Innovation and Technology (BMVIT), the Austrian Federal Ministry for Digital and Economic Affairs (BMDW), the Austrian Research Promotion Agency (FFG), the Province of Styria (SFG), and partners from industry and academia. The COMET Program is managed by FFG. Finally, we acknowledge the Big Data Value Association (BDVA), Brussels, Belgium.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments

  • Çubuk, Cankut
  • Can, Fatma E.
  • Peña-Chilet, María
  • Dopazo, Joaquín
This article belongs to the Special Issue Targeting Signal Transduction Pathways and Non-coding RNAs as Potential Therapy in Cancer and Aging., Despite the existence of differences in gene expression across numerous genes between males and females having been known for a long time, these have been mostly ignored in many studies, including drug development and its therapeutic use. In fact, the consequences of such differences over the disease mechanisms or the drug action mechanisms are completely unknown. Here we applied mechanistic mathematical models of signaling activity to reveal the ultimate functional consequences that gender-specific gene expression activities have over cell functionality and fate. Moreover, we also used the mechanistic modeling framework to simulate the drug interventions and unravel how drug action mechanisms are affected by gender-specific differential gene expression. Interestingly, some cancers have many biological processes significantly affected by these gender-specific differences (e.g., bladder or head and neck carcinomas), while others (e.g., glioblastoma or rectum cancer) are almost insensitive to them. We found that many of these gender-specific differences affect cancer-specific pathways or in physiological signaling pathways, also involved in cancer origin and development. Finally, mechanistic models have the potential to be used for finding alternative therapeutic interventions on the pathways targeted by the drug, which lead to similar results compensating the downstream consequences of gender-specific differences in gene expression., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network "Machine Learning Frontiers in Precision Medicine" (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SMN1 copy-number and sequence variant analysis from next-generation sequencing data

  • López-López, Daniel
  • Loucera, Carlos
  • Carmona, Rosario
  • Aquino, Virginia
  • Salgado-Garrido, Josefa
  • Pasalodos, Sara
  • Miranda, María
  • Alonso, Ángel
  • Dopazo, Joaquín
© 2020 The Authors., Spinal muscular atrophy (SMA) is a severe neuromuscular autosomal recessive disorder affecting 1/10,000 live births. Most SMA patients present homozygous deletion of SMN1, while the vast majority of SMA carriers present only a single SMN1 copy. The sequence similarity between SMN1 and SMN2, and the complexity of the SMN locus makes the estimation of the SMN1 copy-number by next-generation sequencing (NGS) very difficult. Here, we present SMAca, the first python tool to detect SMA carriers and estimate the absolute SMN1 copy-number using NGS data. Moreover, SMAca takes advantage of the knowledge of certain variants specific to SMN1 duplication to also identify silent carriers. This tool has been validated with a cohort of 326 samples from the Navarra 1000 Genomes Project (NAGEN1000). SMAca was developed with a focus on execution speed and easy installation. This combination makes it especially suitable to be integrated into production NGS pipelines. Source code and documentation are available at https://www.github.com/babelomics/SMAca., This study is supported by grants SAF2017‐88908‐R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de RecursosBiomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both cofunded with European Regional Development Funds as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (GA 813533) and “ELIXIR‐EXCELERATE fast‐track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection

  • Loucera, Carlos
  • Esteban-Medina, Marina
  • Rian, Kinza
  • Falco, Matias M.
  • Dopazo, Joaquín
  • Peña-Chilet, María
Drug repurposing is a convenient alternative when the need for new drugs in an unexpected medical scenario is urgent, as is the case of emerging pathogens. In recent years, approaches based on network biology have demonstrated to be superior to genecentric ones.1 Here, we use an innovative methodology that combines mechanistic modeling of the signal transduction circuits related to SARS-CoV-2 infection (the COVID-19 disease map) with a machine-learning algorithm that learns potential causal interactions between proteins, already targets of drugs, and specific signaling circuits in the COVID-19 disease map, to suggest potentially repurposable drugs., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness, PT17/0009/0006, ACCI2018/29 from CIBER-ISCIII and COV20/00788 from the ISCIII, co-funded with European Regional Development Funds (ERDF), the grant “Large-scale drug repurposing in rare diseases by genomic Big Data analysis with machine learning methods” from the Fundación BBVA (G999088Q), as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanistic modeling of the SARS-CoV-2 disease map

  • Rian, Kinza
  • Esteban-Medina, Marina
  • Hidalgo, Marta R.
  • Çubuk, Cankut
  • Falco, Matias M.
  • Loucera, Carlos
  • Gunyel, Devrim
  • Ostaszewski, Marek
  • Peña-Chilet, María
  • Dopazo, Joaquín
Here we present a web interface that implements a comprehensive mechanistic model of the SARS-CoV-2 disease map. In this framework, the detailed activity of the human signaling circuits related to the viral infection, covering from the entry and replication mechanisms to the downstream consequences as inflammation and antigenic response, can be inferred from gene expression experiments. Moreover, the effect of potential interventions, such as knock-downs, or drug effects (currently the system models the effect of more than 8000 DrugBank drugs) can be studied. This freely available tool not only provides an unprecedentedly detailed view of the mechanisms of viral invasion and the consequences in the cell but has also the potential of becoming an invaluable asset in the search for efficient antiviral treatments., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness, PT17/0009/0006, ACCI2018/29 from CIBER-ISCIII and COV20/00788 from the ISCIII, co-funded with European Regional Development Funds (ERDF), the grant “Large-scale drug repurposing in rare diseases by genomic Big Data analysis with machine learning methods” from the Fundación BBVA (G999088Q), as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling

  • López-Sánchez, Macarena
  • Loucera, Carlos
  • Peña-Chilet, María
  • Dopazo, Joaquín
Recent studies have demonstrated a relevant role of the host genetics in the coronavirus disease 2019 (COVID-19) prognosis. Most of the 7000 rare diseases described to date have a genetic component, typically highly penetrant. However, this vast spectrum of genetic variability remains yet unexplored with respect to possible interactions with COVID-19. Here, a mathematical mechanistic model of the COVID-19 molecular disease mechanism has been used to detect potential interactions between rare disease genes and the COVID-19 infection process and downstream consequences. Out of the 2518 disease genes analyzed, causative of 3854 rare diseases, a total of 254 genes have a direct effect on the COVID-19 molecular disease mechanism and 207 have an indirect effect revealed by a significant strong correlation. This remarkable potential of interaction occurs for >300 rare diseases. Mechanistic modeling of COVID-19 disease map has allowed a holistic systematic analysis of the potential interactions between the loss of function in known rare disease genes and the pathological consequences of COVID-19 infection. The results identify links between disease genes and COVID-19 hallmarks and demonstrate the usefulness of the proposed approach for future preventive measures in some rare diseases., Spanish Ministry of Science and Innovation (PID2020-117979RB-I00); Centro de Investigación Biomédica En Red de Enfermedades Raras-Instituto de Salud Carlos III (ACCI2018/29); Instituto de Salud Carlos III (ISCIII), co-funded with European Regional Development Funds (ERDF) (IMP/0019 and COV20/00788); Fundación Banco Bilbao Vizcaya Argentaria (grant G999088Q); grant H2020 Programme of the European Union grants Marie Curie Innovative Training Network ‘Machine Learning Frontiers in Precision Medicine’ (MLFPM; GA 813533); Consejería de Salud y Familias de la Junta de Andalucía (P18-RT-3471); ISCIII (PI20/01305), co-funded with ERDF; Consejería de Salud y Familia (COVID-011-2020); Junta de Andalucía for the postdoctoral contract of Carlos Loucera (PAIDI2020-DOC_00350) co-funded by the European Social Fund (FSE) 2014–2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Integrating pathway knowledge with deep neural networks to reduce the dimensionality in single-cell RNA-seq data

  • Gundogdu, Pelin
  • Loucera, Carlos
  • Alamo-Alvarez, Inmaculada
  • Dopazo, Joaquín
  • Nepomuceno, Isabel
[Background] Single-cell RNA sequencing (scRNA-seq) data provide valuable insights into cellular heterogeneity which is significantly improving the current knowledge on biology and human disease. One of the main applications of scRNA-seq data analysis is the identification of new cell types and cell states. Deep neural networks (DNNs) are among the best methods to address this problem. However, this performance comes with the trade-off for a lack of interpretability in the results. In this work we propose an intelligible pathway-driven neural network to correctly solve cell-type related problems at single-cell resolution while providing a biologically meaningful representation of the data., [Results] In this study, we explored the deep neural networks constrained by several types of prior biological information, e.g. signaling pathway information, as a way to reduce the dimensionality of the scRNA-seq data. We have tested the proposed biologically-based architectures on thousands of cells of human and mouse origin across a collection of public datasets in order to check the performance of the model. Specifically, we tested the architecture across different validation scenarios that try to mimic how unknown cell types are clustered by the DNN and how it correctly annotates cell types by querying a database in a retrieval problem. Moreover, our approach demonstrated to be comparable to other less interpretable DNN approaches constrained by using protein-protein interactions gene regulation data. Finally, we show how the latent structure learned by the network could be used to visualize and to interpret the composition of human single cell datasets., [Conclusions] Here we demonstrate how the integration of pathways, which convey fundamental information on functional relationships between genes, with DNNs, that provide an excellent classification framework, results in an excellent alternative to learn a biologically meaningful representation of scRNA-seq data. In addition, the introduction of prior biological knowledge in the DNN reduces the size of the network architecture. Comparative results demonstrate a superior performance of this approach with respect to other similar approaches. As an additional advantage, the use of pathways within the DNN structure enables easy interpretability of the results by connecting features to cell functionalities by means of the pathway nodes, as demonstrated with an example with human melanoma tumor cells., This work is supported by grants PID2020-117979RB-I00 from the Spanish Ministry of Science and Innovation, IMP/0019 from the Instituto de Salud Carlos III (ISCIII), co-funded with European Regional Development Funds (ERDF); grant H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533); The authors also acknowledge Junta de Andalucía for the postdoctoral contract of Carlos Loucera (PAIDI2020- DOC_00350) co-funded by the European Social Fund (FSE) 2014–2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer

  • Casimiro-Soriguer, Carlos S.
  • Loucera, Carlos
  • Peña-Chilet, María
  • Dopazo, Joaquín
Gut microbiome is gaining interest because of its links with several diseases, including colorectal cancer (CRC), as well as the possibility of being used to obtain non-intrusive predictive disease biomarkers. Here we performed a meta-analysis of 1042 fecal metagenomic samples from seven publicly available studies. We used an interpretable machine learning approach based on functional profiles, instead of the conventional taxonomic profiles, to produce a highly accurate predictor of CRC with better precision than those of previous proposals. Moreover, this approach is also able to discriminate samples with adenoma, which makes this approach very promising for CRC prevention by detecting early stages in which intervention is easier and more effective. In addition, interpretable machine learning methods allow extracting features relevant for the classification, which reveals basic molecular mechanisms accounting for the changes undergone by the microbiome functional landscape in the transition from healthy gut to adenoma and CRC conditions. Functional profiles have demonstrated superior accuracy in predicting CRC and adenoma conditions than taxonomic profiles and additionally, in a context of explainable machine learning, provide useful hints on the molecular mechanisms operating in the microbiota behind these conditions., This work is supported by Grants PID2020-117979RB-I00 from the Spanish Ministry of Science and Innovation and PI20/01305 and IMP/0019 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union Grants Marie Curie Innovative Training Network "Machine Learning Frontiers in Precision Medicine" (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559). The postdoctoral contract for CL PAIDI2020- DOC_00350 is funded by Junta de Andalucía and co-funded by the European Social Fund (FSE) 2014-2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SigPrimedNet: A Signaling-Informed Neural Network for scRNA-seq Annotation of Known and Unknown Cell Types

  • Gundogdu, Pelin
  • Alamo-Alvarez, Inmaculada
  • Nepomuceno-Chamorro, Isabel A.
  • Dopazo, Joaquín
  • Loucera, Carlos
Single-cell RNA sequencing is increasing our understanding of the behavior of complex tissues or organs, by providing unprecedented details on the complex cell type landscape at the level of individual cells. Cell type definition and functional annotation are key steps to understanding the molecular processes behind the underlying cellular communication machinery. However, the exponential growth of scRNA-seq data has made the task of manually annotating cells unfeasible, due not only to an unparalleled resolution of the technology but to an ever-increasing heterogeneity of the data. Many supervised and unsupervised methods have been proposed to automatically annotate cells. Supervised approaches for cell-type annotation outperform unsupervised methods except when new (unknown) cell types are present. Here, we introduce SigPrimedNet an artificial neural network approach that leverages (i) efficient training by means of a sparsity-inducing signaling circuits-informed layer, (ii) feature representation learning through supervised training, and (iii) unknown cell-type identification by fitting an anomaly detection method on the learned representation. We show that SigPrimedNet can efficiently annotate known cell types while keeping a low false-positive rate for unseen cells across a set of publicly available datasets. In addition, the learned representation acts as a proxy for signaling circuit activity measurements, which provide useful estimations of the cell functionalities., This work is supported by grants PID2020-117979RB-I00 and PID2020-117954RB-C22 from the Spanish Ministry of Science and Innovation, IMP/0019 from the Instituto de Salud Carlos III (ISCIII), co-funded with European Regional Development Funds (ERDF); grant H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (MLFPM) (GA 813533). The authors also acknowledge Junta de Andalucía for the postdoctoral contract of Carlos Loucera (PAIDI2020-DOC_00350) co-funded by the European Social Fund (FSE) 2014–2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genetic ancestry in population pharmacogenomics unravels distinct geographical patterns related to drug toxicity

  • Karamperis, Kariofyllis
  • Katz, Sonja
  • Melograna, Federico
  • Ganau, Francesc P.
  • Van Steen, Kristel
  • Patrinos, George P.
  • Lao, Oscar
Genetic ancestry plays a major role in pharmacogenomics, and a deeper understanding of the genetic diversity among individuals holds immerse promise for reshaping personalized medicine. In this pivotal study, we have conducted a large-scale genomic analysis of 1,136 pharmacogenomic variants employing machine learning algorithms on 3,714 individuals from publicly available datasets to assess the risk proximity of experiencing drug-related adverse events. Our findings indicate that Admixed Americans and Europeans have demonstrated a higher risk of experiencing drug toxicity, whereas individuals with East Asian ancestry and, to a lesser extent, Oceanians displayed a lower risk proximity. Polygenic risk scores for drug-gene interactions did not necessarily follow similar assumptions, reflecting distinct genetic patterns and population-specific differences that vary depending on the drug class. Overall, our results provide evidence that genetic ancestry is a pivotal factor in population pharmacogenomics and should be further exploited to strengthen even more personalized drug therapy., GP gratefully acknowledges the funding from the European Union’s Horizon 2020 research and Innovation Programme under the Marie Sklodowska-Curie Grant Agreements No 813533 (MLFPM) and No 860895 (TranSYS), the FNRS convention PDR T.0294.24 “Expanded PRS embracing pathways and interactions for increased clinical utility. O.L. gratefully acknowledges the financial support from the Engineering and Physical Sciences Research Council of UK [grant number EP/X025160/1]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Machine learning in Alzheimer's disease genetics

  • Bracher-Smith, Matthew
  • Pérez-Tur, Jordi
  • Bullido, María Jesús
  • Mir, Pablo
  • Escott-Price, Valentina
16 páginas, 4 figuras, 2 tablas., raditional statistical approaches have advanced our understanding of the genetics of complex diseases, yet are limited to linear additive models. Here we applied machine learning (ML) to genome-wide data from 41,686 individuals in the largest European consortium on Alzheimer's disease (AD) to investigate the effectiveness of various ML algorithms in replicating known findings, discovering novel loci, and predicting individuals at risk. We utilised Gradient Boosting Machines (GBMs), biological pathway-informed Neural Networks (NNs), and Model-based Multifactor Dimensionality Reduction (MB-MDR) models. ML approaches successfully captured all genome-wide significant genetic variants identified in the training set and 22% of associations from larger meta-analyses. They highlight 6 novel loci which replicate in an external dataset, including variants which map to ARHGAP25, LY6H, COG7, SOD1 and ZNF597. They further identify novel association in AP4E1, refining the genetic landscape of the known SPPL2A locus. Our results demonstrate that machine learning methods can achieve predictive performance comparable to classical approaches in genetic epidemiology and have the potential to uncover novel loci that remain undetected by traditional GWAS. These insights provide a complementary avenue for advancing the understanding of AD genetics., Wethank the University of Lille’s Intensive Scientific Computing Mesocentre. M.B.S. and V.E.P. are supported by the UK Dementia Research Institute [UK DRI-3206] through UK DRI Ltd, principally funded by the Medical Research Council and by the UK Medica Research Council: MR/ T04604X/1, MR/P005748/1. K.V.S. has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreements No 813533 (MLFPM) and No 860895 (TranSYS), and FNRS convention PDR T.0294.24 “Expanded PRS embracing pathways and interactions for increased clinical utility”.F.M.(FedericoMelograna)wasalsofundedby the Marie Sklodowska-Curie grant agreement 860895 (TranSYS). J.W. (Julie Williams) is supported by Moondance Dementia Research Laboratory. B.M.T. and G.R. (Gennady Roshchupkin) are funded by ZonMw VIDI (#09150171910068) and ZonMw Veni grant (1936320) respectively.N.A.isfundedbyGSK.RGandADweresupportedbythe Italian Ministry of Health (Ricerca Corrente)., Peer reviewed